SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-19-006616
Filing Date
2019-07-25
Accepted
2019-07-24 20:16:16
Documents
17

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 1748154
2 GRAPHIC g637051g00b84.jpg GRAPHIC 142643
3 GRAPHIC g637051g00s01.jpg GRAPHIC 55332
4 GRAPHIC g637051g14h52.jpg GRAPHIC 69264
5 GRAPHIC g637051g18k68.jpg GRAPHIC 81380
6 GRAPHIC g637051g29d22.jpg GRAPHIC 53235
7 GRAPHIC g637051g41a45.jpg GRAPHIC 123479
8 GRAPHIC g637051g45k40.jpg GRAPHIC 137094
9 GRAPHIC g637051g62r46.jpg GRAPHIC 40349
10 GRAPHIC g637051g63k39.jpg GRAPHIC 59134
11 GRAPHIC g637051g63m97.jpg GRAPHIC 64222
12 GRAPHIC g637051g64b64.jpg GRAPHIC 100708
13 GRAPHIC g637051g65h63.jpg GRAPHIC 115909
14 GRAPHIC g637051g68y78.jpg GRAPHIC 80256
15 GRAPHIC g637051g83j48.jpg GRAPHIC 79157
16 GRAPHIC g637051g85l16.jpg GRAPHIC 140472
17 GRAPHIC g637051g90g21.jpg GRAPHIC 221288
  Complete submission text file 0000950123-19-006616.txt   3904341
Mailing Address 700 ALEXANDER PARK DRIVE SUITE 301 PRINCETON NJ 08540
Business Address 700 ALEXANDER PARK DRIVE SUITE 301 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Filer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-02750 | Film No.: 19972171
SIC: 2836 Biological Products, (No Diagnostic Substances)